We invite contributions to our workshop on using large language models (LLMs) in the history, philosophy, and sociology of science (HPSS). The workshop will focus on exploring use cases and proposals for how, and to what extent, LLMs might help overcome long-standing challenges in studies of how science works. The event will take place from April 2–4, 2025, at Technische Universität Berlin, Germany. Attendance (online and on site) will be free and open to the public but registration will be required. To contribute a talk, please submit abstracts of 300–600 words by December 31, 2024, to arno.simons@tu-berlin.de
April 2-4, 2025, Technische Universität Berlin, Germany
Organized by: Gerd Graßhoff, Arno Simons, Adrian Wüthrich, and Michael Zichert more info...
Paper submissions are invited for the special issue of Topoi entitled: Rethinking Human-Centredness: Bridging Environmental and AI Ethical Discourses. In the face of pressing issues such as climate change, the loss of biodiversity, AI-driven surveillance, biases embedded in machine learning algorithms, the special issue aims to critically examine the concept of human-centeredness in the field of applied ethics and from both historical and systematic perspectives (see the details for more about issue description and topics).
Special issue article publications often bring higher citations and visibility than regular papers and attract more relevant readership due to its scope. Topoi is indexed in the Web of Science under AHCI, currently in Quartile 1 and placed in the top-10 ranked Philosophy-Category journals, with a 2023 IF of 1,3 and CiteScore of 3,1.
April 5, 2025 @ 8:00 am - April 6, 2025 @ 5:00 pm EDT
Senior Visiting Fellow Conference by Carl Hoefer
The evidence-based medicine (EBM) movement began in the 1980s, reached its peak perhaps in the 1990s, and has since then enjoyed the status of orthodoxy, despite many criticisms being raised among medical practitioners and researchers. Philosophers of medicine have frequently criticized EBM’s hierarchies and rigid precepts, especially the “gold standard” status of randomized controlled trials (RCTs). A pluralistic approach to evidence in medicine has been increasingly popular in recent years, in which mechanistic evidence and reasoning, observational studies of many kinds and RCTs are assessed for value on a case-by-case basis. But does this trend away from the EBM hierarchy go too far and risk the reintroduction of the same biased, motivated evidence-gathering practices that originally motivated the EBM movement? What light can recent experiences in medicine and public health (e.g., during the covid-19 pandemic) shed on these issues?
The evidence-based medicine (EBM) movement began in the 1980s, reached its peak perhaps in the 1990s, and has since then enjoyed the status of orthodoxy, despite many criticisms being raised among medical practitioners and researchers. Philosophers of medicine have frequently criticized EBM’s hierarchies and rigid precepts, especially the “gold standard” status of randomized controlled trials (RCTs). A pluralistic approach to evidence in medicine has been increasingly popular in recent years, in which mechanistic evidence and reasoning, observational studies of many kinds and RCTs are assessed for value on a case-by-case basis. But does this trend away from the EBM hierarchy go too far and risk the reintroduction of the same biased, motivated evidence-gathering practices that originally motivated the EBM movement? What light can recent experiences in medicine and public health (e.g., during the covid-19 pandemic) shed on these issues?
